A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa
- Bwakura-Dangarembizi, M
- Kendall, L
- Bakeera-Kitaka, S
- Nahirya-Ntege, P
- Keishanyu, R
- Nathoo, K
- Spyer, MJ
- Kekitiinwa, A
- Lutaakome, J
- Mhute, T
- Kasirye, P
- Munderi, P
- Musiime, V
- Gibb, DM
- Walker, AS
- Prendergast, AJ
- Antiretroviral Research for Watoto (ARROW) Trial Team,
DOIAbstract
Co-trimoxazole (fixed-dose trimethoprim-sulfamethoxazole) prophylaxis administered before antiretroviral therapy (ART) reduces morbidity in children infected with the human immunodeficiency virus (HIV). We investigated whether children and adolescents receiving long-term ART in sub-Saharan Africa could discontinue co-trimoxazole
.jpg%3Fwidth%3D300&w=3840&q=75)
Add to ORKG